Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling.
Author(s) -
Kosei Yamauchi,
Kim Milarski,
Alan R. Saltiel,
Jeffrey E. Pessin
Publication year - 1995
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.92.3.664
Subject(s) - protein tyrosine phosphatase , grb10 , biology , sh2 domain , tyrosine phosphorylation , insulin receptor , phosphorylation , proto oncogene tyrosine protein kinase src , sh3 domain , tyrosine , dephosphorylation , microbiology and biotechnology , insulin receptor substrate , irs1 , phosphotyrosine binding domain , biochemistry , phosphatase , insulin , endocrinology , insulin resistance
SHPTP2 is a ubiquitously expressed tyrosine-specific protein phosphatase that contains two amino-terminal Src homology 2 (SH2) domains responsible for its association with tyrosine-phosphorylated proteins. In this study, expression of dominant interfering mutants of SHPTP2 was found to inhibit insulin stimulation of c-fos reporter gene expression and activation of the 42-kDa (Erk2) and 44-kDa (Erk1) mitogen-activated protein kinases. Cotransfection of dominant interfering SHPTP2 mutants with v-Ras or Grb2 indicated that SHPTP2 regulated insulin signaling either upstream of or in parallel to Ras function. Furthermore, phosphotyrosine blotting and immunoprecipitation identified the 125-kDa focal adhesion kinase (pp125FAK) as a substrate for insulin-dependent tyrosine dephosphorylation. These data demonstrate that SHPTP2 functions as a positive regulator of insulin action and that insulin signaling results in the dephosphorylation of tyrosine-phosphorylated pp125FAK.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom